Billionaire donates $220m for peak performance research

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Salk Institute, UC San Diego and Stanford given $220 million by Wu Tsai Human Performance Alliance to research molecular underpinnings of peak human performance.

A Salk Institute team led by Professor Satchin Panda, along with teams from five other organisations, have been awarded a total of $220 million by the Joe and Clara Tsai Foundation’s Human Performance Alliance, whose philanthropic investment aims to transform human health on a global scale through the discovery and translation of the biological principles underlying human performance.

Longevity.Technology: Coinciding with the opening of the Tokyo Olympics, this benefaction would seem to be the largest ever made for sports-related health and medical research. By understanding and leveraging elite athletes’ endurance, resilience and recovery rate, as well as unlocking their genetic gifts, longevity research should be able to take up this baton and run with it, harnessing this knowledge for therapies that delay or ameliorate aging. We’ll be watching with interest!

“Scientific funding has traditionally been focused on the study of diseases,” Clara Wu Tsai said in a statement this week. “We are taking the opposite approach and studying the human body at its healthiest and most vital, to enable the thriving of all people — from an Olympic Gold Medal-level athlete to a grandfather lacking the mobility to enjoy a full life [1].”

Salk Institute President Rusty Gage commented: “The Institute has long been known for its discoveries into cellular mechanisms that lead to disease, but, like the Alliance, Salk is also very focused on maintaining health. This generous gift from Clara Wu and Joe Tsai to study performance will greatly help Salk reveal new insights into better performance for athletes and better health for everyone [2].”

Panda, a world expert in how human biological clocks contribute to health or disease, will lead the Salk team to map the molecules and gene activity of human performance that can help maximise performance, healing and recovery.

“The Human Performance Alliance’s dedication to uncovering the principles of elite athletic performance to help all people live stronger, healthier, more fulfilling lives is truly commendable,” says Panda, who holds the Rita and Richard Atkinson Chair. “It aligns completely with my vision of circadian rhythms in metabolism, repair and rejuvenation, as well as with the Salk Institute’s deep commitment to basic research for the benefit of all humanity [2].”

Ovarian Longevity webinar

Panda’s research centres on circadian rhythms, the 24-hour cycles that govern our internal body clocks. His lab has found that hundreds to thousands of genes in our genome turn on and off in different organs at specific times during the 24-hour day. His body of work suggests that there may be optimal times for activities such as eating, sleeping and working out that, in turn, reduce tissue damage and promote optimal healing to sustain high performance.

While the Salk Institute carry the torch for genes and molecules and their part in healing and recovery, UCSD will work on models that are better at predicting the effects of tissue changes on the body. Overviewing the musculoskeletal system (bones, muscles, ligaments, tendons and soft tissue) will shine a light on problems that are prevalent in an aging population, such as arthritis and frailty. It is estimated that 126 million Americans alone suffer from musculoskeletal problems, so research in this area could make great strides in improving healthspan.

As one of four “scientific moonshoots” being led by a team of faculty collaborators from different disciplines and multiple institutions across the country as part of the Human Performance Alliance, the Molecular Athlete moonshot is based at the Salk Institute. The Salk team will work on uncovering the molecular signatures of performance, and will collaborate with teams at UC San Diego, Stanford University, the University of Kansas, the University of Oregon and Boston Children’s Hospital to translate scientific findings into practice.

The data generated by the Human Alliance will be freely available globally, to ensure its commitment to collaboration, diversity and inclusivity.

Ovarian Longevity webinar

[1] https://www.lajollalight.com/news/story/2021-07-21/la-jolla-billionaire-couple-donate-220-million-to-study-health-lessons-to-be-learned-from-elite-athletes
[2] https://www.salk.edu/news-release/salk-institute-among-cross-collaborative-teams-gifted-220-million-by-wu-tsai-human-performance-alliance/

Image courtesy of the Salk Institute
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...
Nutriop